A carregar...
Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer
INTRODUCTION: Concurrent signal transduction inhibition with the epidermal growth factor receptor (EGFR) inhibitor gefitinib and the mammalian target-of-rapamycin inhibitor everolimus has been hypothesized to result in enhanced antitumor activity in patients with non-small cell lung cancer (NSCLC)....
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4020424/ https://ncbi.nlm.nih.gov/pubmed/20871262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181ec1531 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|